Cargando…
Immunotherapy: A new target for cancer cure (Review)
Cancer is the leading cause of death globally and there is a worldwide cancer epidemic. Immunotherapy has emerged as a promising anticancer therapy. In particular, oncolytic viruses destroy cancer cells without destroying normal tissue via viral self-replication and anti-tumor immune responses, show...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091078/ https://www.ncbi.nlm.nih.gov/pubmed/36999633 http://dx.doi.org/10.3892/or.2023.8537 |
_version_ | 1785023081931079680 |
---|---|
author | Zhao, Fuqian Shen, Daofu Shang, Mingquan Yu, Hao Zuo, Xiaoxue Chen, Lixin Huang, Zhijin Li, Lianxing Wang, Lei |
author_facet | Zhao, Fuqian Shen, Daofu Shang, Mingquan Yu, Hao Zuo, Xiaoxue Chen, Lixin Huang, Zhijin Li, Lianxing Wang, Lei |
author_sort | Zhao, Fuqian |
collection | PubMed |
description | Cancer is the leading cause of death globally and there is a worldwide cancer epidemic. Immunotherapy has emerged as a promising anticancer therapy. In particular, oncolytic viruses destroy cancer cells without destroying normal tissue via viral self-replication and anti-tumor immune responses, showing potential for cancer therapy. The present review discusses the role of the immune system in the treatment of tumor. The strategies for treating tumors are briefly introduced from aspects of active immunization and passive immunotherapy and the dendritic cell vaccines and oncolytic viruses are highlighted, as well as use of blood group A antigen in the treatment of solid tumors. |
format | Online Article Text |
id | pubmed-10091078 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-100910782023-04-13 Immunotherapy: A new target for cancer cure (Review) Zhao, Fuqian Shen, Daofu Shang, Mingquan Yu, Hao Zuo, Xiaoxue Chen, Lixin Huang, Zhijin Li, Lianxing Wang, Lei Oncol Rep Review Cancer is the leading cause of death globally and there is a worldwide cancer epidemic. Immunotherapy has emerged as a promising anticancer therapy. In particular, oncolytic viruses destroy cancer cells without destroying normal tissue via viral self-replication and anti-tumor immune responses, showing potential for cancer therapy. The present review discusses the role of the immune system in the treatment of tumor. The strategies for treating tumors are briefly introduced from aspects of active immunization and passive immunotherapy and the dendritic cell vaccines and oncolytic viruses are highlighted, as well as use of blood group A antigen in the treatment of solid tumors. D.A. Spandidos 2023-03-28 /pmc/articles/PMC10091078/ /pubmed/36999633 http://dx.doi.org/10.3892/or.2023.8537 Text en Copyright: © Zhao et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Review Zhao, Fuqian Shen, Daofu Shang, Mingquan Yu, Hao Zuo, Xiaoxue Chen, Lixin Huang, Zhijin Li, Lianxing Wang, Lei Immunotherapy: A new target for cancer cure (Review) |
title | Immunotherapy: A new target for cancer cure (Review) |
title_full | Immunotherapy: A new target for cancer cure (Review) |
title_fullStr | Immunotherapy: A new target for cancer cure (Review) |
title_full_unstemmed | Immunotherapy: A new target for cancer cure (Review) |
title_short | Immunotherapy: A new target for cancer cure (Review) |
title_sort | immunotherapy: a new target for cancer cure (review) |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091078/ https://www.ncbi.nlm.nih.gov/pubmed/36999633 http://dx.doi.org/10.3892/or.2023.8537 |
work_keys_str_mv | AT zhaofuqian immunotherapyanewtargetforcancercurereview AT shendaofu immunotherapyanewtargetforcancercurereview AT shangmingquan immunotherapyanewtargetforcancercurereview AT yuhao immunotherapyanewtargetforcancercurereview AT zuoxiaoxue immunotherapyanewtargetforcancercurereview AT chenlixin immunotherapyanewtargetforcancercurereview AT huangzhijin immunotherapyanewtargetforcancercurereview AT lilianxing immunotherapyanewtargetforcancercurereview AT wanglei immunotherapyanewtargetforcancercurereview |